(PharmaNewsWire.Com, April 07, 2017 ) Asia-Pacific Diabetic Retinopathy Market research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 7.94% to reach USD 2.15 billion by 2021, from USD 1.46 billion in 2016, which amounts to a cumulative growth of USD 0.63 billion.
Asia- Pacific region is expected to show wealthy growth in forecast period . within western pacific region and Asian region accounted for large share of blindness because of DE which is equated to south east asia. The factors which are contributing to rise share of the market among the rising economies are huge pool of patients and growth in support and funding by government.
Diabetic retinopathy is considered as a severe sight threatening problem that results due to chronic diabetes. The treatment for diabetic retinopathy may require intraocular injections, laser surgery, anti VEGF drugs or vitrectomy depending on severity of condition.
The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are
Rapidly expanding diabetic population coupled increasing awareness of people regarding diabetic retinopathy Rising medical procedures due to high penetration of medical insurance rising government initiatives for prevention of diabetes related risks
For granular level understanding the Diabetic Retinopathy Market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Type of Treatment, Market is segmented as Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. Based on Indication, Market is segmented as Non-Proliferative Diabetic Retinopathy (NPDR) (Mild, Moderate and Severe and Proliferative Diabetic Retinopathy (PDR). Based on End Users, Market is segmented as Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers.
With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. Some of the key players that operate in the Asia-Pacific Diabetic Retinopathy market include Bayer AG, Hoffmann-La Roche ltd, Novartis AG, Valeant Pharmaceutical International Inc., Alimera Science Inc, Ampio Pharmaceuticals Inc. Pfizer Inc., Regeneron Pharmaceutical Inc., and Abbott Laboratories Inc.,
The Asia- Pacific Diabetic Retinopathy market report offers wide-range of scope:
Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
Know more about key areas of industry growth via detailedSegment-level analysis on basis of type of treatment, indication and end-user along with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containingPESTLE and Porters Five Forces Analyseswhich are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunitiesdevised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the therapeutics Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
